Skip to main content
TipRanks
Go Ultimate75% OFF

John Knopf Insider Profile

4 Followers

John Knopf, former CEO & President, Director at Acceleron Pharma, holds 119.08K shares in Acceleron Pharma (Ticker: XLRN).

John Knopf's Trading History

XLRN
Acceleron Pharma
Mar 07, 2016―Uninformative Buy―$21.29M
XLRN
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Mar 07, 2016Uninformative Buy$0.0017,500$0.00―
Oct 09, 2015Uninformative Sell$463.29K19,000$24.38―
Sep 15, 2015Informative Buy$3.40K8,500$0.40-4.50%
Sep 11, 2015Uninformative Buy$0.0089,000$0.00―
Sep 10, 2015Uninformative Sell$573.89K19,000$30.20―

You May Also Like

John Knopf insider profile FAQ

What is the percentage of profitable transactions made by John Knopf?
The percentage of profitable transactions made by John Knopf is 33%.
What is the average return per transaction made by John Knopf?
The average return per transaction made by John Knopf is 2.20%.
What stocks does John Knopf hold?
John Knopf holds: XLRN stocks.
What was John Knopf's most profitable transaction?
John Knopf’s most profitable transaction was an Informative Buy of XLRN stock on August 3, 2015. The return on the trade was 17.70%.
What is John Knopf's role in Acceleron Pharma?
John Knopf's role in Acceleron Pharma is CEO & President, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.